Aging Disorders of the Eye: Challenges and Approaches for Their Treatment

Hazare, Shruti; Yang, Rongbing; Chavan, Smita Akshay; Menon, Mala; Chougule, Mahavir B.

doi:10.1007/978-3-319-29346-2_14

Search citation statements

Order By: Relevance

Paper Sections

Select...

Age-related Macular Degeneration1

Diabetic Retinopathy1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(2 citation statements)

References 177 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is often one of the earliest symptoms of wet AMD. 51 Micro/nano-application. Kompella et al utilized solvent evaporation to formulate poly lactic acid (PLA) MPs of polymericbudesonide, which inhibits the expression of VEGF.…”

Section: Age-related Macular Degenerationmentioning

confidence: 99%

“…This disease can be attributed to a major proportion of all visual impairment and irreversible blindness cases worldwide. 51,58,59 DR is a vascular disorder of the retina, which occurs as a complication of diabetes mellitus. Vision loss associated with DR may be caused by various mechanisms, such as neovascularization leading to vitreous hemorrhage or retinal detachment or macular edema and retinal capillary nonperfusion.…”

Section: Diabetic Retinopathymentioning

confidence: 99%

See 1 more Smart Citation

Micro/Nanoparticle Delivery Systems for Ocular Diseases

Halasz

Kelly

Iqbal

et al. 2019

ASSAY and Drug Development Technologies

View full text Add to dashboard Cite

Micro-(MPs) and nanoparticles (NPs) have been recently studied for their application in ophthalmic drug delivery. These drug delivery systems are able to circumvent the ocular barriers that currently limit the efficacy of conventional treatments, as well as provide a more sustained release of drug, reducing the frequency of administration and increasing patient compliance. This review summarizes the recent trends in ophthalmic research from conventional treatment to the utilization of MPs and NPs as drug carriers.

show abstract

Section: Age-related Macular Degenerationmentioning

confidence: 99%

Section: Diabetic Retinopathymentioning

confidence: 99%